Medical field veteran joins SomaLogic as CFO
BOULDER — SomaLogic Inc., a protein-analysis bioscience company that expects to go public via a merger with special purpose acquisition company CM Life Sciences II (Nasdaq: CMIIU), has hired Shaun Blakeman as the company’s new chief financial officer.
He takes over the role from Matthew Norkunas.
Most recently, Blakeman was chief financial officer at Cantel Medical Corp. (NYSE: CMD). He has also had leadership roles at Medtronic Inc.
SPONSORED CONTENT
How Platte River Power Authority is accelerating its energy transition
Platte River Power Authority, the community-owned wholesale electricity provider for Northern Colorado, has a history of bold initiatives.
“We are thrilled to welcome Shaun Blakeman to the SomaLogic team,” SomaLogic CEO Roy Smythe said in a prepared statement. “His depth of experience as a financial executive across a range of medical technology companies materially strengthens our leadership team and will make an immediate impact as we continue to rapidly scale our business.”
© 2021 BizWest Media LLC
BOULDER — SomaLogic Inc., a protein-analysis bioscience company that expects to go public via a merger with special purpose acquisition company CM Life Sciences II (Nasdaq: CMIIU), has hired Shaun Blakeman as the company’s new chief financial officer.
He takes over the role from Matthew Norkunas.
Most recently, Blakeman was chief financial officer at Cantel Medical Corp. (NYSE: CMD). He has also had leadership roles at Medtronic Inc.
“We are thrilled to welcome Shaun Blakeman to the SomaLogic team,” SomaLogic CEO Roy Smythe said in a prepared statement. “His depth of experience as a financial executive across a range of medical technology companies…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!